Schering creates new role for Jorn

Schering-Plough has appointed Deborah Jorn a group vice president, global allergy/respiratory marketing, primary care customer group, a new position. Jorn joins from Johnson & Johnson, where she was worldwide vice president, internal medicine, early commercial input and emerging franchises. She previously worked at Pharmacia, where she was global vice president for Detrol/Detrusitol and urology.
She reports to Ellen Geisel, senior vice president, primary care customer group, and is responsible for the company's global allergy and respiratory franchise, including Nasonex and Clarinex.
You must be a registered member of MMM to post a comment.

Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.